An2 Therapeutics, Inc. · NASDAQ:ANTX
Frazier Life Sciences Public Fund, L.P.'s stake in An2 Therapeutics, Inc. fell below 5% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Frazier Life Sciences Public Fund, L.P.'s stake in An2 Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 14 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 0% | 0 |
| FHMLSP, L.P. | 0% | 0 |
| FHMLSP, L.L.C. | 0% | 0 |
| Frazier Life Sciences X, L.P. | 0% | 0 |
| FHMLS X, L.P. | 0% | 0 |
| FHMLS X, L.L.C. | 0% | 0 |
| Frazier Life Sciences XI, L.P. | 0% | 0 |
| FHMLS XI, L.P. | 0% | 0 |
| FHMLS XI, L.L.C. | 0% | 0 |
| James N. Topper | 0% | 0 |
| Patrick J. Heron | 0% | 0 |
| Albert Cha | 0% | 0 |
| James Brush | 0% | 0 |
| Daniel Estes | 0% | 0 |
Source
Related
- An2 Therapeutics, Inc.
- Frazier Life Sciences Public Fund, L.P.
- An2 Therapeutics, Inc. shareholders
- Form 4 · Aziz Kabeer · Oct 13, 2026
- Form 4 · Martin Patricia A. · Oct 13, 2026
- Form 4 · Marks Gilbert Lynn · Oct 13, 2026
- Form 4 · Trenor Cameron C. III · Sep 16, 2026
- Form 4 · Readnour Robin Shane · Sep 11, 2026